Transgenic Angiopoietin-Like (Angptl)4 Overexpression and Targeted Disruption of Angptl4 and Angptl3: Regulation of Triglyceride Metabolism
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Lipoprotein lipase (LPL) is a key regulator of triglyceride clearance. Its coordinated regulation during feeding and fasting is critical for maintaining lipid homeostasis and energy supply. Angiopoietin-like (Angptl)3 and Angptl4 are secreted proteins that have been demonstrated to regulate triglyceride metabolism by inhibiting LPL. We have taken a targeted genetic approach to generate Angptl4- and Angptl3-deficient mice as well as transgenic mice overexpressing human Angptl4 in the liver. The Angptl4 transgenic mice displayed elevated plasma triglycerides and reduced postheparin plasma (PHP) LPL activity. A purified recombinant Angptl4 protein inhibited mouse LPL and recombinant human LPL activity in vitro. In contrast to the transgenic mice, Angptl4-deficient mice displayed hypotriglyceridemia and increased PHP LPL activity, with greater effects in the fasted compared with the fed state. Angptl3-deficient mice also displayed hypotriglyceridemia with elevated PHP LPL activity, but these mice showed a greater effect in the fed state. Mice deficient in both Angptl proteins showed an additive effect on plasma triglycerides and did not survive past 2 months of age. Our results show that Angptl3 and Angptl4 function to regulate circulating triglyceride levels during different nutritional states and therefore play a role in lipid metabolism during feeding/fasting through differential inhibition of LPL.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ANGPTL3 inhibits the lipoprotein lipase, which results in increased blood lipid levels [143–145].”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [143]
In the citing paper
“Evinacumab is a monoclonal antibody inhibiting angiopoietin-like 3 (ANGPTL3).”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [143]
In the citing paper
“In contrast to other pharmacological treatments, evinacumab’s MoA is therefore independent of the LDL-C receptor [143, 148], providing new options for more synergistic combination treatments.”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [143]
In the citing paper
“Thus, Angptl4 knockout mice have reduced plasma triglycerides, whereas Angptl4 overexpressing mice have increased triglyceride levels [9,10].”
From Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity (2015) · cites this paper as [9]
In the citing paper
“Conversely, ANGPTL4-deficient mice had lower than normal plasma triglycerides and higher postheparin-plasma LPL activity (16).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [16]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Enzyme kinetics; behavior and analysis of rapid equilibrium and steady state enzyme systems
(1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90021-3 · Cited by 2,972
Lipoprotein lipase: structure, function, regulation, and role in disease
Mead, J., Irvine, S., & Ramji, D. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 927
Merkel, M., Eckel, R. H., & Goldberg, I. J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200015-jlr200 · Cited by 522
Kersten, S., Mandard, S., Tan, N. S., Escher, P., Metzger, D., Chambon, P., Gonzalez, F. J., Desvergne, B., & Wahli, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004029200 · Cited by 489
Angptl3 regulates lipid metabolism in mice
Koishi, R., Ando, Y., Ono, M., Shimamura, M., Yasumo, H., Fujiwara, T., Horikoshi, H., & Furukawa, H. (2002) · Nature Genetics · doi:10.1038/ng814 · Cited by 379
Yoon, J. C., Chickering, T. W., Rosen, E. D., Dussault, B., Qin, Y., Soukas, A., Friedman, J. M., Holmes, W. E., & Spiegelman, B. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5343-5349.2000 · Cited by 356
Shimizugawa, T., Ono, M., Shimamura, M., Yoshida, K., Ando, Y., Koishi, R., Ueda, K., Inaba, T., Minekura, H., Kohama, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203215200 · Cited by 339
Yoshida, K., Shimizugawa, T., Ono, M., & Furukawa, H. (2002) · Journal of Lipid Research · doi:10.1194/jlr.c200010-jlr200 · Cited by 317
Kim, I., Kim, H.-G., Kim, H. W., Kim, H.-H., Park, S. K., Uhm, C.-S., Lee, Z. H., & Koh, G. Y. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460603 · Cited by 284
Weinstock, P. H., Bisgaier, C. L., Aalto-Setälä, K., Radner, H., Ramakrishnan, R., Levak-Frank, S., Essenburg, A. D., Zechner, R., & Breslow, J. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118319 · Cited by 254
Cited by
Items 101–200 of 427
Calandra, S., Tarugi, P., Speedy, H. E., Dean, A. F., Bertolini, S., & Shoulders, C. C. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r017855 · Cited by 87
Ruscica, M., Zimetti, F., Adorni, M. P., Sirtori, C. R., Lupo, M. G., & Ferri, N. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104653 · Cited by 82
Prevalence of ANGPTL3 and APOB Gene Mutations in Subjects With Combined Hypolipidemia
Noto, D., Cefalù, A. B., Valenti, V., Fayer, F., Pinotti, E., Ditta, M., Spina, R., Vigna, G., Yue, P., Kathiresan, S., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.238766 · Cited by 81
Kroupa, O., Vorrsjö, E., Stienstra, R., Mattijssen, F., Nilsson, S. K., Sukonina, V., Kersten, S., Olivecrona, G., & Olivecrona, T. (2012) · BMC Physiology · doi:10.1186/1472-6793-12-13 · Cited by 73
“Inactivation of Angptl4 in mice is associated with low plasma triglycerides and high postheparin LPL activity [10].”
BackgroundMethodResultInfluentialFu, Z., Abou-Samra, A. B., & Zhang, R. (2015) · Scientific Reports · doi:10.1038/srep18502 · Cited by 82
Mehta, N., Qamar, A., Qu, L., Qasim, A. N., Mehta, N. N., Reilly, M. P., & Rader, D. J. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302802 · Cited by 80
Adachi, H., Fujiwara, Y., Kondo, T., Nishikawa, T., Ogawa, R., Matsumura, T., Ishii, N., Nagai, R., Miyata, K., Tabata, M., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.018 · Cited by 80
Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1
Lichtenstein, L., & Kersten, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.015 · Cited by 89
Daniels, A., van Bilsen, M., Janssen, B. J., Brouns, A. E., Cleutjens, J. P. M., Roemen, T. H. M., Schaart, G., van der Velden, J., Vusse, G. J., & van Nieuwenhoven, F. A. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02102.x · Cited by 87
“Angptl4 is a secreted protein known to affect lipid metabolism via inhibition of lipoprotein lipase (LPL) activity, thereby limiting the uptake of VLDL- and chylomicron-derived FA by the heart (Yoshida et al. 2002, Koster et al. 2005, Xu et al. 2005).”
BackgroundKristensen, K. K., Leth-Espensen, K. Z., Mertens, H. D. T., Birrane, G., Meiyappan, M., Olivecrona, G., Jørgensen, T. J. D., Young, S. G., & Ploug, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920202117 · Cited by 72
ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells
Liu, X., Yu, X., Xie, J., Zhan, M., Yu, Z., Xie, L., Zeng, H., Zhang, F., Chen, G., Yi, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4217 · Cited by 73
“Similarly, ANGPTLs have been demonstrated to play crucial roles in lipid metabolism and angiogenesis [34, 16, 35], and our previous study showed that LILRB2 inhibits differentiation and promotes self-renewal of HSCs and LSCs; however, the function of LILRB2 in cancer progression remains unclear.”
Li, Y., & Teng, C. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.928715 · Cited by 83
“In mice, the effects of ANGPTL4 deficiency is same with ANGPTL3 deficiency [27,32,41], while in humans, the sequence variations in ANGPTL4 are associated with only lowering of the plasma triglyceride levels [27,39].”
BackgroundThe Lipoprotein Lipase Inhibitor ANGPTL3 Is Negatively Regulated by Thyroid Hormone
Fugier, C., Tousaint, J.-J., Prieur, X., Plateroti, M., Samarut, J., & Delerive, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512554200 · Cited by 60
Cinkajzlová, A., Mráz, M., Lacinová, Z., Kloučková, J., Kaválková, P., Kratochvílová, H., Trachta, P., Křížová, J., Haluzíková, D., Škrha, J., et al. (2018) · Nutrition & Diabetes · doi:10.1038/s41387-018-0032-2 · Cited by 73
Folsom, A. R., Peacock, J. M., Demerath, E., & Boerwinkle, E. (2008) · Metabolism · doi:10.1016/j.metabol.2008.06.016 · Cited by 64
“Conversely, an ANGPTL4 knockout mouse has reduced plasma triglyceride concentrations because of increased VLDL clearance and decreased VLDL production and has modestly lower cholesterol levels [15,17].”
Dijk, W., Ruppert, P. M. M., Oost, L. J., & Kersten, S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002426 · Cited by 72
“WT and Angptl4 / mice on a C57Bl/6 background were used that were bred and maintained in the same facility for more than 20 generations (51).”
MethodAngiopoietin-like 4 Is a Wnt Signaling Antagonist that Promotes LRP6 Turnover
Kirsch, N., Chang, L.-S., Koch, S., Glinka, A., Dolde, C. E., Colozza, G., Benitez, M. D. J., Robertis, E. M. D., & Niehrs, C. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.09.011 · Cited by 79
“Moreover, mice mutant for Angptl4 are viable (Desai et al., 2007; Koster et al., 2005), although some unaccounted embryonic lethality has been observed (Perdiguero et al., 2011).”
BackgroundGenetics and regulation of angiopoietin-like proteins 3 and 4
Li, C. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000217896.67444.05 · Cited by 70
Fasting induces ANGPTL4 and reduces LPL activity in human adipose tissue
Ruppert, P. M. M., Michielsen, C. C. J. R., Hazebroek, E. J., Pirayesh, A., Olivecrona, G., Afman, L. A., & Kersten, S. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101033 · Cited by 69
Angiopoietin-like protein 4: health effects, modulating agents and structure–function relationships
Grootaert, C., Van de Wiele, T., Verstraete, W., Bracke, M., & Vanhoecke, B. (2012) · Expert Review of Proteomics · doi:10.1586/epr.12.12 · Cited by 69
Genetic and Genomic Insights into the Molecular Basis of Atherosclerosis
Chen, Y., Rollins, J. A., Paigen, B. J., & Wang, X. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.07.001 · Cited by 70
Advances in biological therapies for dyslipidemias and atherosclerosis
Valanti, E.-K., Dalakoura-Karagkouni, K., Siasos, G., Kardassis, D., Eliopoulos, A. G., & Sanoudou, D. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154461 · Cited by 72
Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation
Li, J., Li, L., Guo, D., Li, S., Zeng, Y., Liu, C., Fu, R., Huang, M., & Xie, W. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.029 · Cited by 76
Fatty Acids and their Proteins in Adipose Tissue Inflammation
Mallick, R., Basak, S., Das, R. K., Banerjee, A., Paul, S., Pathak, S., & Duttaroy, A. K. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01185-6 · Cited by 73
“In adipose tissue, the role of ANGPTL4 in ectopic lipid deposition [139], metabolism of lipids [140, 141], glucose homeostasis[137, 142], and vascular disease [143] are emerging.”
BackgroundMartín-Campos, J. M., Roig, R., Mayoral, C., Martinez, S., Martí, G., Arroyo, J. A., Julve, J., & Blanco-Vaca, F. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.11.020 · Cited by 65
“The effect of ANGPTL3 on plasma TG has been reported to be dominant in the fed, but not in the fasting, state [20].”
BackgroundLi, X., Zhu, M., Penfold, M. E., Koenen, R. R., Thiemann, A., Heyll, K., Akhtar, S., Koyadan, S., Wu, Z., Gremse, F., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006840 · Cited by 64
“results in hypertriglyceridemia and hypercholesterolemia in mice.(41,42) Moreover, chronic intermittent hypoxia increases VLDL levels, reduces adipose Lpl activity, and promotes ath-”
BackgroundInsulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes
Yamada, T., Ozaki, N., Kato, Y., Miura, Y., & Oiso, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.032 · Cited by 69
Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues
Yao, Q., Shin, M., Jun, J. C., Hernandez, K. L., Aggarwal, N. R., Mock, J. R., Gay, J. P., Drager, L. F., & Polotsky, V. Y. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m034272 · Cited by 72
Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects
Lupo, M. G., & Ferri, N. (2018) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd5030039 · Cited by 63
“LOF mutations on ANGPTL4 develop into a hypolipidemic phenotype [65,66].”
BackgroundChi, X., Shetty, S. K., Shows, H. W., Hjelmaas, A. J., Malcolm, E. K., & Davies, B. S. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.623769 · Cited by 63
“Increasing plasma levels of ANGPTL4, either by overexpression in the liver or by direct injection of ANGPTL4 into the bloodstream, can reduce plasma triglycerides in mice (21, 45), suggesting that ANGPTL4 can act on the LPL-GPIHBP1 complexes in the vasculature.”
BackgroundFurin Is the Primary in Vivo Convertase of Angiopoietin-like 3 and Endothelial Lipase in Hepatocytes
Essalmani, R., Susan-Resiga, D., Chamberland, A., Asselin, M.-C., Canuel, M., Constam, D., Creemers, J. W., Day, R., Gauthier, D., Prat, A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.501304 · Cited by 54
“It would be highly informative in the future to test whether similar conclusions could also be reached for LPL, ANGPTL4, and ANGPTL8.”
BackgroundInfluentialAnti-diabetic effect of pyroglutamic acid in type 2 diabetic Goto-Kakizaki rats and KK-Aymice
Yoshinari, O., & Igarashi, K. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511001279 · Cited by 65
“Li(31) and Köster et al.(32) have reported that Angptl4 has been shown to inhibit lipoprotein lipase (LPL) activity and increase plasma TAG.”
BackgroundRahib, L., MacLennan, N. K., Horvath, S., Liao, J. C., & Dipple, K. M. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201801 · Cited by 68
Ingerslev, B., Hansen, J. S., Hoffmann, C., Clemmesen, J. O., Secher, N. H., Scheler, M., Hrabĕ de Angelis, M., Häring, H. U., Pedersen, B. K., Weigert, C., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.018 · Cited by 61
Heinonen, S. E., Kivelä, A. M., Huusko, J., Dijkstra, M. H., Gurzeler, E., Mäkinen, P. I., Leppänen, P., Olkkonen, V. M., Eriksson, U., Jauhiainen, M., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt148 · Cited by 61
“It has been shown that Angptl4 deficiency in mice leads to increased levels of heparin-releasable LPL activity and decreased plasma triglyceride levels, whereas overexpression of Angptl4 decreases LPL activity and increases plasma triglycerides.(23)”
BackgroundNew wrinkles in lipoprotein lipase biology
Davies, B. S. J., Beigneux, A. P., Fong, L. G., & Young, S. G. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834d0b33 · Cited by 59
“A variety of proteins that regulate LPL have been identified, including apo-CII [12,13], apo-CIII [14], apo-AV [15–17], angiopoietin-like protein 3 (ANGPTL3) [18,19], and ANGPTL4 [18].”
BackgroundInfluentialThe Apolipoprotein M/S1P Axis Controls Triglyceride Metabolism and Brown Fat Activity
Christoffersen, C., Federspiel, C. K., Borup, A., Christensen, P. M., Madsen, A. N., Heine, M., Nielsen, C. H., Kjær, A., Holst, B., Heeren, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.029 · Cited by 65
“Notably, plasma ANGPLT4, which regulates the activity of LPL (Dijk et al., 2015; Köster et al., 2005), was similar in Apom / mice and wild-type mice (data not shown).”
BackgroundInfluentialBishop, J. R., Passos‐Bueno, M. R., Fong, L. G., Stanford, K. I., Gonzales, J. C., Yeh, E., Young, S. G., Bensadoun, A., Witztum, J. L., Esko, J. D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013919 · Cited by 59
“Lpl expression and activity are normal in Col18a1 mice The delayed lipolysis of plasma triglycerides in Col18a1 mice could reflect deficiencies in various factors involved in Lplmediated turnover, including angiopoietin-like 4 [27], caveolin-1 [28], and apolipoprotein C-II [29].”
BackgroundDutton, S., & Trayhurn, P. (2008) · British Journal of Nutrition · doi:10.1017/s0007114507882961 · Cited by 60
Schaap, F. G., Nierman, M. C., Berbée, J. F. P., Hattori, H., Talmud, P. J., Vaessen, S. F. C., Rensen, P. C. N., Chamuleau, R. A. F. M., Kuivenhoven, J. A., & Groen, A. K. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500533-jlr200 · Cited by 58
Hepatokines—A novel group of exercise factors
Weigert, C., Hoene, M., & Plomgaard, P. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-2216-y · Cited by 57
Rodríguez‐Acebes, S., Palacios, N., Botella-Carretero, J. I., Olea, N., Crespo, L., Peromingo, R., Gómez‐Coronado, D., Lasunción, M. A., Vázquez, C., & Martínez-Botas, J. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-61 · Cited by 67
“Thus, Angptl4-deficient mice are hypolipidemic and have increased lipoprotein lipase activity [52], whereas Angptl4 adenovirus-mediated overexpression potently increases plasma triglycerides, decreases blood glucose, and improves glucose tolerance [53,54].”
McQueen, A. E., Kanamaluru, D., Yan, K., Gray, N. E., Wu, L., Li, M.-L., Chang, A., Hasan, A., Stifler, D., Koliwad, S. K., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.803973 · Cited by 56
“Adenoviral overexpression of full-length human ANGPTL4 in mice causes severe hypertriglyceridemia and hepatic steatosis, whereas mice lacking the gene encoding Angptl4 (Angptl4 / ) have much lower plasma and liver TG levels than WT controls (15).”
BackgroundEffects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes
Christopoulou, E. C., Elisaf, M., & Filippatos, T. D. (2019) · Disease Markers · doi:10.1155/2019/6578327 · Cited by 60
“Accordingly, mice lacking ANGPTL3 have increased LPL activity and reduced levels of TRG and FFA [19, 22, 24].”
BackgroundEffects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism
Minicocci, I., Tikka, A., Poggiogalle, E., Metso, J., Montali, A., Ceci, F., Labbadia, G., Fontana, M., Di Costanzo, A., Maranghi, M., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.p066183 · Cited by 56
Insights from human congenital disorders of intestinal lipid metabolism
Levy, E. H. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r052415 · Cited by 64
Camp, J. G., Jazwa, A. L., Trent, C. M., & Rawls, J. F. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002585 · Cited by 56
“The presence of a gut microbiota also results in a concomitant reduction in intestinal expression of Angiopoietin-like 4 (Angptl4, also called Fiaf, Pgar, and Hfarp) [8,11], encoding a circulating peptide hormone that acts as a direct inhibitor of LPL activity [12–15].”
BackgroundDetermination of lipoprotein lipase activity using a novel fluorescent lipase assay
Basu, D., Manjur, J., & Jin, W. (2011) · Journal of Lipid Research · doi:10.1194/jlr.d010744 · Cited by 56
Dang, F., Wu, R., Wang, P., Wu, Y., Azam, M. S., Xu, Q., Chen, Y., & Liu, Y. (2016) · Scientific Reports · doi:10.1038/srep36926 · Cited by 57
Ibeagha-Awemu, E. M., Li, R., Ammah, A. A., Dudemaine, P.-L., Bissonnette, N., Benchaar, C., & Zhao, X. (2016) · BMC Genomics · doi:10.1186/s12864-016-2423-x · Cited by 59
“It was shown in transgenic mice that ANGPTL3 and ANGPTL4 regulated circulating triglyceride levels under different nutritional regimes and thus play roles in lipid metabolism through differential inhibition of lipoprotein lipase [77].”
BackgroundKuchtey, J., Ka¨llberg, M. E., Gelatt, K. N., Rinkoski, T., Koma`romy, A. M., & Kuchtey, R. W. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1347 · Cited by 55
Role of exercise-induced hepatokines in metabolic disorders
Ennequin, G., Sirvent, P., & Whitham, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2018 · Cited by 54
The glucocorticoid-Angptl4-ceramide axis induces insulin resistance through PP2A and PKCζ
Chen, T.-C., Benjamin, D. I., Kuo, T., Lee, R. A., Li, M.-L., Mar, D. J., Costello, D. E., Nomura, D. K., & Wang, J.-C. (2017) · Science Signaling · doi:10.1126/scisignal.aai7905 · Cited by 60
Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus
Trebotic, L. K., Klimek, P., Thomas, A., Fenzl, A., Leitner, K., Springer, S., Kiefer, F. W., & Kautzky‐Willer, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136701 · Cited by 52
“Betatrophin may also act in concert with other angiopoietin-like protein family members such as ANGPTL3 [4, 13], a known regulator of cholesterol metabolism in mice and humans [14, 15].”
BackgroundExposure to Arsenic at Levels Found in U.S. Drinking Water Modifies Expression in the Mouse Lung
Andrew, A. S., Bernardo, V., Warnke, L. A., Davey, J. C., Hampton, T. H., Mason, R. A., Thorpe, J. E., Ihnat, M. A., & Hamilton, J. W. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm200 · Cited by 58
“In addition to other roles, Angptl4 inhibits lipoprotein lipase, an enzyme that regulates triglyceride clearance and lipid homeostasis (Koster et al., 2005).”
BackgroundOteng, A.-B., Ruppert, P. M., Boutens, L., Dijk, W., van Dierendonck, X. M. H., Olivecrona, G., Stienstra, R., & Kersten, S. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m094128 · Cited by 46
“The role of ANGPTL3/ANGPTL8 in LPL regulation is particularly important in the fed state (18).”
BackgroundA unified model for regulating lipoprotein lipase activity
Zhang, R., & Zhang, K. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.02.016 · Cited by 56
Zwartjes, M., Gerdes, V. E. A., & Nieuwdorp, M. (2021) · Metabolites · doi:10.3390/metabo11080531 · Cited by 58
Basu, D., & Bornfeldt, K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00504 · Cited by 52
Circulating Betatrophin Levels Are Increased in Anorexia and Decreased in Morbidly Obese Women
Barja-Fernández, S., Folgueira, C., Seoane, L. M., Casanueva, F. F., Diéguez, C., Castelao, C., Agüera, Z., Baños, R., Botella, C., de la Torre, R., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1595 · Cited by 53
Roberts, R., Chang, C. C., & Hadley, T. D. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.09.004 · Cited by 65
Immunopathogenesis of idiopathic nephrotic syndrome with relapse
Sahali, D., Sendeyo, K., Mangier, M., Audard, V., Zhang, S. Y., Lang, P., Ollero, M., & Pawlak, A. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-013-0415-3 · Cited by 52
Mendelian Disorders of High-Density Lipoprotein Metabolism
Oldoni, F., Sinke, R. J., & Kuivenhoven, J. A. (2014) · Circulation Research · doi:10.1161/circresaha.113.300634 · Cited by 49
“Angptl4 KO mice exhibit increased LPL activity, 65% to 90% lower TG levels, slightly lower total cholesterol levels, lower HDL-C, and circulating VLDL,(230,231) whereas transgenic mice have reduced postheparin plasma LPL activity and elevated plasma triglycerides.(231) Angptl3 KO mice also show lower plasma triglyceri…”
BackgroundAcquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells
Zhang, Z., Cao, L., Li, J., Liang, X., Liu, Y., Liu, H., Du, J., Qu, Z., Cui, M., Liu, S., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.010 · Cited by 49
Effects of iron loading on muscle: genome-wide mRNA expression profiling in the mouse
Rodríguez, A., Hilvo, M., Kytömäki, L., Fleming, R. E., Britton, R. S., Bacon, B. R., & Parkkila, S. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-379 · Cited by 52
“adenoviral over-expression [42].”
Traumatic brain injury induces adipokine gene expression in rat brain.
Brown, R. E., Thompson, H., Imran, S., Ur, E., & Wilkinson, M. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.008 · Cited by 45
ANGPTL4 is produced by entero-endocrine cells in the human intestinal tract
Alex, S., Lichtenstein, L., Dijk, W., Mensink, R. P., Tan, N. S., & Kersten, S. (2014) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1157-y · Cited by 37
Wang, Y., Liu, L.-M., Wei, L., Ye, W.-W., Meng, X.-Y., Chen, F., Xiao, Q., Chen, J.-Y., & Zhou, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5637 · Cited by 46
“In addition, it has been reported that the blood lipid levels were reduced in Angptl4 knockout mice, and significantly increased with ectopic Angptl4 overexpression (6,7).”
Angiopoietin-Like 4 Regulates Epidermal Differentiation
Pal, M., Tan, M., Huang, R.-L., Goh, Y. Y., Wang, X. L., Tang, M. B. Y., & Tan, N. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025377 · Cited by 50
Pan, D., Wang, W., Liu, N., Yang, Q., Zhang, K., Zhu, J.-Z., Shan, S., Li, Z., Ning, Z., Huang, L., et al. (2017) · PPAR Research · doi:10.1155/2017/4313561 · Cited by 47
Jahn, D., Dorbath, D., Schilling, A.-K., Gildein, L., Meier, C. F., Vuille-dit-Bille, R. N., Schmitt, J., Kraus, D., Fleet, J. C., Hermanns, H. M., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.03.007 · Cited by 44
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia
Tarugi, P., Bertolini, S., & Calandra, S. (2018) · Journal of Biomedical Research · doi:10.7555/jbr.32.20170114 · Cited by 47
Koliwad, S. K., Gray, N. E., & Wang, J.-C. (2012) · Adipocyte · doi:10.4161/adip.20787 · Cited by 50
“Loss of function of ANGPTL3 can have lipidlowering effects.(31) Additionally, it is worth noting that ANGPTL5 expression is relatively high in human WAT.”
BackgroundMining the genome for lipid genes
Kuivenhoven, J. A., & Hegele, R. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.028 · Cited by 52
“Knockout [95,96] Hypertriglyceridemia”
Barja-Fernández, S., Moreno‐Navarrete, J. M., Folgueira, C., Xifra, G., Sabater, M., Castelao, C., Fernø, J., Leis, R., Diéguez, C., Casanueva, F. F., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800060 · Cited by 45
Ortega-Senovilla, H., Schaefer-Graf, U., Meitzner, K., Abou-Dakn, M., & Herrera, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1614 · Cited by 42
ANGPTL3: a novel biomarker and promising therapeutic target
Jiang, S., Qiu, G.-H., Zhu, N., Hu, Z., Liao, D., & Li, Q. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1566342 · Cited by 43
“LPL Direct Coiled-coid domain Inhibition [4,9] EL Direct Coiled-coid domain Inhibition [4,9] avb3 Direct Fribrinogen-like domain Promotion [3] FAK Indirect None Promotion [3,66,67] MAPK Indirect None Promotion [3,66] PKB Indirect None Promotion [3,66] MMP-9 Indirect None Promotion [60–61] ERK Indirect None Promotion […”
BackgroundRegulation of plasma triglyceride partitioning by adipose-derived ANGPTL4 in mice
Spitler, K. M., Shetty, S. K., Cushing, E. M., Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-87020-5 · Cited by 42
The Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase Activity
Wen, Y., Chen, Y., & Konrad, R. J. (2022) · Advanced Biology · doi:10.1002/adbi.202200093 · Cited by 53
Gutgsell, A. R., Ghodge, S. V., Bowers, A. A., & Neher, S. B. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005932 · Cited by 41
Repression of glucocorticoid-stimulated angiopoietin-like 4 gene transcription by insulin
Kuo, T., Chen, T.-C., Yan, S. L., Foo, F., Ching, C., McQueen, A., & Wang, J.-C. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m047860 · Cited by 40
Hanson, R. L., Leti, F., Tsinajinnie, D., Kobes, S., Puppala, S., Curran, J. E., Almasy, L., Lehman, D. M., Blangero, J., Duggirala, R., et al. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.04.007 · Cited by 40
“Several studies have shown that ANGPTL3 inhibits lipoprotein lipase (LPL) activity in vitro (53, 57, 61, 62), and ANGPTL3−/− mice have higher LPL activity (52, 57, 63).”
BackgroundPramfalk, C., Parini, P., Gustafsson, U., Sahlin, S., & Eriksson, M. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02305.x · Cited by 40
Lipoprotein Lipase and Its Delivery of Fatty Acids to the Heart
Shang, R., & Rodrigues, B. B. (2021) · Biomolecules · doi:10.3390/biom11071016 · Cited by 45
“This idea arose from a study where ANGPTL4 deficiency caused an elevation of post-heparin plasma LPL activity in mice [56].”
BackgroundThe transcriptomic profiles of adipose tissues are modified by feed deprivation in lactating goats
Faulconnier, Y., Chilliard, Y., Torbati, M. B. M., & Leroux, C. (2010) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2010.12.002 · Cited by 47
Bini, S., D’Erasmo, L., Costanzo, A. D., Minicocci, I., Pecce, V., & Arca, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020742 · Cited by 41
Izumi, R., Kusakabe, T., Noguchi, M., Iwakura, H., Tanaka, T., Miyazawa, T., Aotani, D., Hosoda, K., Kangawa, K., & Nakao, K. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m082099 · Cited by 37
“However, neither Angptl3 nor Angptl4 KO mice showed a significant change in body weight compared with WT mice (46).”
BackgroundInfluentialChellan, B., Rojas, E., Zhang, C., & Bowman, M. A. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-30073-w · Cited by 41
Makoveichuk, E., Sukonina, V., Kroupa, O., Thulin, P., Ehrenborg, E., Olivecrona, T., & Olivecrona, G. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.048 · Cited by 39
Li, S., Nagothu, K. K., Ranganathan, G., Ali, S. M., Shank, B. B., Gökden, N., Ayyadevara, S., Megyesi, J. K., Olivecrona, G., Chugh, S. S., et al. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00111.2012 · Cited by 38
The angiopoietin-like protein 3: a hepatokine with expanding role in metabolism
Arca, M., Minicocci, I., & Maranghi, M. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283630cf0 · Cited by 37
“Consistent with these findings, targeted deletion of ANGPTL3 (Angptl / ) caused lower plasma triglyceride in mice [20].”
BackgroundFunctional validation of new pathways in lipoprotein metabolism identified by human genetics
Bauer, R. C., Stylianou, I. M., & Rader, D. J. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834469b3 · Cited by 36
Structural characterization of ANGPTL8 (betatrophin) with its interacting partner lipoprotein lipase
Siddiqa, A., Ahmad, J., Ali, A., Paracha, R. Z., Bibi, Z., & Aslam, B. (2016) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2016.01.009 · Cited by 37
Hepatokines as a Molecular Transducer of Exercise
Seo, D. Y., Park, S.-H., Marquez, J. C., Kwak, H., Kim, T. N., Bae, J. H., Koh, J., & Han, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030385 · Cited by 39
“The overexpression of ANGPTL4 in mice is associated with reduced LPL activity as well as increased circulating TG and cholesterol levels compared to control animals [83].”
BackgroundLegry, V., Bokor, S., Cottel, D., Béghin, L., Catasta, G., Nagy, E., González‐Gross, M., Spinneker, A., Stehle, P., Molnár, D., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0769 · Cited by 41
Raal, F. J., Rosenson, R. S., Reeskamp, L. F., Kastelein, J. J. P., Rubba, P., Duell, P. B., Koseki, M., Stroes, E., Ali, S., Banerjee, P., et al. (2023) · JACC: Advances · doi:10.1016/j.jacadv.2023.100648 · Cited by 34
Host biomarkers distinguish dengue from leptospirosis in Colombia: a case–control study
Conroy, A. L., Gélvez, M., Hawkes, M., Rajwans, N., Liles, W. C., Villar, L. A., & Kain, K. C. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-35 · Cited by 33
“Angptl3 plays a role in lipid metabolism [47], hematopoietic stem cell activity [48], angiogenesis [49], and endothelial permeability in the glomerulus [50].”
BackgroundBen-Zvi, D., Barrandon, O., Hadley, S., Blum, B., Peterson, Q. P., & Melton, D. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513872112 · Cited by 34
“This is a surprising finding, which can be explained by Angptl4 suppression of hepatic gluconeogenesis (52) through the altered inflammatory response in mesenteric lymph nodes of angptl4 fed with saturated fats (46) or by the overall altered lipid composition of angptl4 plasma that affects insulin and glucagon secreti…”
BackgroundTheofilatos, D., Fotakis, P., Valanti, E., Sanoudou, D., Zannis, V. I., & Kardassis, D. (2018) · Metabolism · doi:10.1016/j.metabol.2018.06.002 · Cited by 38
Jin, N., Matter, W. F., Michael, L. F., Qian, Y., Gheyi, T., Cano, L., Perez, C., Lafuente, C., Broughton, H. B., & Espada, A. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00954 · Cited by 36
Metadata
- Authors
- Köster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., Heuer, J. G., Jaskunas, S. R., & Eacho, P.
- Affiliations
- Eli Lilly (United States) (US)
- Takeda Oncology (United States) (US)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-11-01
- Volume
- 146
- Issue
- 11
- Pages
- 4943-4950
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2117617326
- Semantic Scholar
- 6382419c744ba19464b065395484df9cb3cf3eaf
- Cited by
- 427
- References
- 36
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 14 · 2023: 15 · 2022: 11 · 2021: 41 · 2020: 26 · 2019: 20 · 2018: 33 · 2017: 21 · 2016: 23 · 2015: 26 · 2014: 27 · 2013: 29 · 2012: 22
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Keywords
- ANGPTL4, ANGPTL3, lipoprotein lipase, triglyceride metabolism, hypotriglyceridemia, plasma triglycerides, lipoprotein lipase inhibition, fasting and feeding, lipid homeostasis, knockout mice, transgenic mice
- MeSH terms
- Angiopoietin-like Proteins, Angiopoietin-Like Protein 4, Angiopoietin-Like Protein 3, Animals, Fasting, Heparin, Humans, Hyperlipidemias, Lipoprotein Lipase, Mice, Transgenic, Recombinant Proteins, Triglycerides, Survival Analysis, Mice, Knockout, Postprandial Period, Intercellular Signaling Peptides and Proteins, Angiopoietins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.